Literature DB >> 20090131

Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study.

Nargis Begum1, Salam Gyaneshwori Devi, Syed A Husain, P Kar.   

Abstract

BACKGROUND &
OBJECTIVE: Hepatitis E virus (HEV) is a major public health problem in the developing countries. HEV infection in pregnant women is more common and fatal in the third trimester. The mortality rate due to HEV-induced hepatitis is as high as 15-20 per cent. The present study was designed to determine the seroprevalence of subclinical HEV infection in pregnant primigravidae women.
METHODS: A total of 300 asymptomatic healthy primigravidae (gestational age 16-24 wk) with no history of jaundice were included in the study. Prevalence of anti-HEV antibodies was determined by an enzyme linked immunosorbent assay (ELISA) kit.
RESULTS: The overall prevalence of seropositive HEV IgG was 33.67 per cent among the pregnant women. The seropositivity of HEV IgG was significantly high in urban population (P<0.05), and related with the period of settlement (P<0.05) and source of water (P=0.05). Low socio-economic status of the pregnant women appeared to be the only risk factor (OR=1.96, CI=1.17-3.28) associated with HEV IgG antibody. INTERPRETATION &amp;
CONCLUSION: In the present study, exposure to HEV during pregnancy was higher in urban (slum areas) than rural population. Socio-economic status was a risk factor for anti-HEV IgG in pregnant women. Early preventive measures if taken, may decrease the maternal and perinatal mortality and morbidity of HEV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20090131

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  19 in total

1.  A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.

Authors:  Yueyuan Zhao; Xuefeng Zhang; Fengcai Zhu; Hui Jin; Bei Wang
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

2.  Hepatobiliary quiz-8 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-12

Review 3.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

4.  Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: A prospective study from Western India.

Authors:  Dattatray Solanke; Chetan Rathi; Vikas Pandey; Mallanagoud Patil; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2016-10-31

Review 5.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  Developing and validating a modified enzyme linked immunosorbent assay method for detecting HEV IgG antibody from dried blood spot (DBS) samples in endemic settings.

Authors:  Rosy Sultana; Taufiqur Rahman Bhuiyan; Afsana Shirin Sathi; Salma Sharmin; Sharmina Yeasmin; Muhammad Ikhtear Uddin; Md Saruar Bhuiyan; Kaiissar Mannoor; Muhammad Manjurul Karim; K Zaman; Firdausi Qadri
Journal:  Microbes Infect       Date:  2021-10-07       Impact factor: 2.700

7.  Frequency of Acute Viral Hepatitis A, B, C, and E in Pregnant Women Presenting to Hayatabad Medical Complex, Peshawar, Pakistan.

Authors:  Ahmad R Khan; Salma Waqar; Zainab Rafiq; Rizwan Ullah; Muhammad Hayyan Wazir; Ayesha M Gul
Journal:  Cureus       Date:  2022-04-17

8.  An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.

Authors:  Seong Eun Jin; Jung-Eun Kim; Sun Yeou Kim; Bang Ju Park; Yoon-Jae Song
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

9.  Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt.

Authors:  Yahia Z Gad; Nasser Mousa; Maher Shams; Ahmed Elewa
Journal:  Asian J Transfus Sci       Date:  2011-07

10.  Hepatitis E- Is it a risk to transfusion safety?

Authors:  Naveen Kumar; Shiv Kumar Sarin
Journal:  Asian J Transfus Sci       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.